Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 2/20 | 0.56 |
| ▸ | CNR2 | P34972 | 2/20 | 0.56 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18381376 | 0.84 | FAAH (0.55) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL18381256 | 0.82 | SLC6A5 (0.57) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL19059536 | 0.81 | SLC6A5 (0.52) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL17325320 | 0.76 | SLC6A5 (0.55) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL19059414 | 0.76 | SLC6A5 (0.70) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL2176441 | 0.75 | CYP3A4 (0.51) | FAAHCNR1CNR2SLC6A5CYP3A4 | |
| SCHEMBL19051541 | 0.75 | SLC6A5 (0.50) | FAAHCNR1CNR2SLC6A5CYP3A4 | |
| SCHEMBL19051597 | 0.75 | SLC6A5 (0.52) | FAAHCNR1CNR2SLC6A5TBXAS1 | |
| SCHEMBL19051482 | 0.74 | SLC6A5 (0.53) | FAAHCNR1CNR2SLC6A5CYP3A4 | |
| SCHEMBL19051563 | 0.74 | SLC15A2 (0.52) | FAAHCNR1CNR2SLC6A5TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170183318-A1 | AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES" (RU) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183318-A1 | AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES | ACE, ACE2, MCTS1 | FAAH 271/4885CNR1 1805/4885CNR2 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.